主权项 |
1. A method for treating a patient with colorectal cancer that has metastasized to the patient's liver and/or lung comprising the step of administering to the patient a therapeutically effective amount of one or more drugs that target at least two of the following proteins, if two or more of the proteins are found to be elevated in a sample of the metastatic cancer from the patient: pAKT, pSTAT3, pVEGFR, pFKHR-FICHRL1, pcKit, pShc, pSMAD2, pSrc, pSTAT5, pAbl, pJak1, pPyk2, pPDGFRb, pPRAS40, and pEGFR, wherein the drugs are selected from the group consisting of Imatinib mesylate, Bevacizumab, Erlotinib hydrochloride, Panitumumab, Lapatinib, an akt inhibitor, and a PI3 kinase inhibitor. |